---
layout: post
title: "Identification of Medicinal Products-Implementation and Use; Guidance for Industry; Availability"
date: 2026-02-05 18:36:05 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-06587
original_published: 2023-03-30 00:00:00 +0000
significance: 8.00
---

# Identification of Medicinal Products-Implementation and Use; Guidance for Industry; Availability

**Published:** February 05, 2026 18:36 UTC
**Source:** Federal Register
**Original Published:** March 30, 2023 00:00 UTC
**Document Number:** 2023-06587

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry entitled "Identification of Medicinal Products--Implementation and Use." This guidance explains FDA's position and progress on aligning the Agency's standards to Identification of Medicinal Products (IDMP) standards, which the Agency supports, to identify and describe marketed medicinal products with the exception of investigational medicinal products, with the goal of harmonizing the standards for the international exchange of medicinal product data. The guidance is intended to assist sponsors, applicants, and registrants who are involved in the regulatory submission of medicinal product data.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/30/2023-06587/identification-of-medicinal-products-implementation-and-use-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2023-06587

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
